|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||166.22 g/mol g·mol−1|
Phenoxypropazine (trade name Drazine) is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was introduced as an antidepressant in 1961, but was subsequently withdrawn in 1966 due to hepatotoxicity concerns.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|